Are nasal steroids effective in children with adenoid hypertrophy?

Basit Öğe Kaydı
dc.authorid
dc.contributor.authorSolmaz, Fevzi
dc.contributor.authorAşcıoğlu, Mustafa Erhan
dc.contributor.authorDurgut, Osman
dc.contributor.authorDikici, Oğuzhan
dc.contributor.authorHaksever, Mehmet
dc.contributor.authorAkduman, Davut
dc.date.accessioned2021-12-01T18:24:07Z
dc.date.available2021-12-01T18:24:07Z
dc.date.issued2019
dc.department[Belirlenecek]en_US
dc.description.abstractObjectives: Chronic nasal obstruction is a common disease of childhood. Adenotonsillar hypertrophy playsan important role in obstructive sleep apnea. The topical use of the aerosolized forms of corticosteroids thereforeseems the most appropriate route to decrease systemic side effects. The aim of our study is to demonstrate theeffect of topical mometasone furoate especially on the adenoid volume in patients without any allergic story.Methods: The study group consisting of 30 males and 25 females was administered topical nasal mometasonefuroate steroid treatment. The 20 patients were in the control group where saline solution (0.9% NaCl) treatmentwas administered consisted of 12 males and 8 females. Nasopharyngeal X-rays before treatment revealed that25 patients were Grade 2 and 30 patients were Grade 3 according to the Fujioka method.Results: Flexible endoscopy performed before the treatment revealed that 20 patients were Grade 2, 11 patientswere Grade 3 and 24 patients were Grade 4. Nasal endoscopies performed after 6 weeks of intranasal topicalsteroid therapy revealed that 45 patients were Grade 1 and 10 patients were Grade 2. A statistically significantdifference was present between endoscopic grades before and after treatment (p < 0.0001). Nasal endoscopiesperformed after 6 weeks in control group receiving saline solution treatment revealed Grade 2 in 7 patients,Grade 3 in 10 patients and Grade 4 in 3 patients. There was no statistically significant difference between inthe prior and later grades of the control group (p = 0.3125).Conclusions: We believe that the use of intranasal steroids (mometasone furoate) for 6 weeks in patients withpediatric chronic nasal obstruction due to adenoid hypertrophy may be an effective treatment modality inalleviating symptoms and decreasing adenoid volume without causing systemic side effects.en_US
dc.identifier.doi10.18621/eurj.405439
dc.identifier.endpage318en_US
dc.identifier.issn2149-3189
dc.identifier.issn2149-3189
dc.identifier.issue2en_US
dc.identifier.startpage311en_US
dc.identifier.urihttps://doi.org/10.18621/eurj.405439
dc.identifier.urihttps://app.trdizin.gov.tr/makale/TkRBME1EUTNOdz09
dc.identifier.urihttps://hdl.handle.net/20.500.12684/9835
dc.identifier.volume5en_US
dc.indekslendigikaynakTR-Dizinen_US
dc.language.isoenen_US
dc.relation.ispartofThe European Research Journalen_US
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subject[No Keywords]en_US
dc.titleAre nasal steroids effective in children with adenoid hypertrophy?en_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
9835.pdf
Boyut:
306.65 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir

Koleksiyon

TR-Dizin İndeksli Yayınlar Koleksiyonu